Viewing StudyNCT05194163



Ignite Creation Date: 2024-05-06 @ 5:06 PM
Last Modification Date: 2024-10-26 @ 2:22 PM
Study NCT ID: NCT05194163
Status: NOT_YET_RECRUITING
Last Update Posted: 2022-03-29
First Post: 2022-01-13

Brief Title: MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimers Disease
Sponsor:
Organization: Neurokine Therapeutics

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 24
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: